338 related articles for article (PubMed ID: 24036851)
61. Gambogenic acid-induced time- and dose-dependent growth inhibition and apoptosis involving Akt pathway inactivation in U251 glioblastoma cells.
Chen HB; Zhou LZ; Mei L; Shi XJ; Wang XS; Li QL; Huang L
J Nat Med; 2012 Jan; 66(1):62-9. PubMed ID: 21879332
[TBL] [Abstract][Full Text] [Related]
62. TROY signals through JAK1-STAT3 to promote glioblastoma cell migration and resistance.
Ding Z; Kloss JM; Tuncali S; Tran NL; Loftus JC
Neoplasia; 2020 Sep; 22(9):352-364. PubMed ID: 32629176
[TBL] [Abstract][Full Text] [Related]
63. Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma.
Koul D; Shen R; Bergh S; Lu Y; de Groot JF; Liu TJ; Mills GB; Yung WK
Mol Cancer Ther; 2005 Nov; 4(11):1681-8. PubMed ID: 16275989
[TBL] [Abstract][Full Text] [Related]
64. Protein Kinase CK2 Controls CD8
Yang W; Wei H; Benavides GA; Turbitt WJ; Buckley JA; Ouyang X; Zhou L; Zhang J; Harrington LE; Darley-Usmar VM; Qin H; Benveniste EN
J Immunol; 2022 Sep; 209(5):896-906. PubMed ID: 35914835
[TBL] [Abstract][Full Text] [Related]
65. CK2 inhibitor CX-4945 suppresses DNA repair response triggered by DNA-targeted anticancer drugs and augments efficacy: mechanistic rationale for drug combination therapy.
Siddiqui-Jain A; Bliesath J; Macalino D; Omori M; Huser N; Streiner N; Ho CB; Anderes K; Proffitt C; O'Brien SE; Lim JK; Von Hoff DD; Ryckman DM; Rice WG; Drygin D
Mol Cancer Ther; 2012 Apr; 11(4):994-1005. PubMed ID: 22267551
[TBL] [Abstract][Full Text] [Related]
66. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
[TBL] [Abstract][Full Text] [Related]
67. Inhibiting casein kinase 2 overcomes paclitaxel resistance in gastric cancer.
Jung M; Park KH; Kim HM; Kim TS; Zhang X; Park SM; Beom SH; Kim HS; Cheong JH; Chung HC; Soong J; Lin SC; Rha SY
Gastric Cancer; 2019 Nov; 22(6):1153-1163. PubMed ID: 31098863
[TBL] [Abstract][Full Text] [Related]
68. Blocking the bFGF/STAT3 interaction through specific signaling pathways induces apoptosis in glioblastoma cells.
Wu J; Feng X; Zhang B; Li J; Xu X; Liu J; Wang X; Wang J; Tong X
J Neurooncol; 2014 Oct; 120(1):33-41. PubMed ID: 25048528
[TBL] [Abstract][Full Text] [Related]
69. PI3K p110β isoform synergizes with JNK in the regulation of glioblastoma cell proliferation and migration through Akt and FAK inhibition.
Zhao HF; Wang J; Jiang HR; Chen ZP; To SS
J Exp Clin Cancer Res; 2016 May; 35():78. PubMed ID: 27176481
[TBL] [Abstract][Full Text] [Related]
70. Integrin αVβ3 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repair.
Christmann M; Diesler K; Majhen D; Steigerwald C; Berte N; Freund H; Stojanović N; Kaina B; Osmak M; Ambriović-Ristov A; Tomicic MT
Oncotarget; 2017 Apr; 8(17):27754-27771. PubMed ID: 27487141
[TBL] [Abstract][Full Text] [Related]
71. Nuclear localization of the CK2α-subunit correlates with poor prognosis in clear cell renal cell carcinoma.
Rabjerg M; Guerra B; Oliván-Viguera A; Mikkelsen ML; Köhler R; Issinger OG; Marcussen N
Oncotarget; 2017 Jan; 8(1):1613-1627. PubMed ID: 27906674
[TBL] [Abstract][Full Text] [Related]
72. Xihuang pill potentiates the anti-tumor effects of temozolomide in glioblastoma xenografts through the Akt/mTOR-dependent pathway.
Fu J; Zhu SH; Xu HB; Xu YQ; Wang X; Wang J; Kong PS
J Ethnopharmacol; 2020 Oct; 261():113071. PubMed ID: 32603676
[TBL] [Abstract][Full Text] [Related]
73. Ciclopirox and bortezomib synergistically inhibits glioblastoma multiforme growth via simultaneously enhancing JNK/p38 MAPK and NF-κB signaling.
Su Z; Han S; Jin Q; Zhou N; Lu J; Shangguan F; Yu S; Liu Y; Wang L; Lu J; Li Q; Cai L; Wang C; Tian X; Chen L; Zheng W; Lu B
Cell Death Dis; 2021 Mar; 12(3):251. PubMed ID: 33674562
[TBL] [Abstract][Full Text] [Related]
74. LYG-202 augments tumor necrosis factor-α-induced apoptosis via attenuating casein kinase 2-dependent nuclear factor-κB pathway in HepG2 cells.
Chen FH; Lu N; Zhang HW; Zhao L; He LC; Sun HP; You QD; Li ZY; Guo QL
Mol Pharmacol; 2012 Nov; 82(5):958-71. PubMed ID: 22909797
[TBL] [Abstract][Full Text] [Related]
75. Targeting protein kinase CK2 suppresses bladder cancer cell survival via the glucose metabolic pathway.
Zhang X; Yang X; Yang C; Li P; Yuan W; Deng X; Cheng Y; Li P; Yang H; Tao J; Lu Q
Oncotarget; 2016 Dec; 7(52):87361-87372. PubMed ID: 27888634
[TBL] [Abstract][Full Text] [Related]
76. Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survival.
Mizoguchi M; Betensky RA; Batchelor TT; Bernay DC; Louis DN; Nutt CL
J Neuropathol Exp Neurol; 2006 Dec; 65(12):1181-8. PubMed ID: 17146292
[TBL] [Abstract][Full Text] [Related]
77. A CK2-dependent mechanism for activation of the JAK-STAT signaling pathway.
Zheng Y; Qin H; Frank SJ; Deng L; Litchfield DW; Tefferi A; Pardanani A; Lin FT; Li J; Sha B; Benveniste EN
Blood; 2011 Jul; 118(1):156-66. PubMed ID: 21527517
[TBL] [Abstract][Full Text] [Related]
78. Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.
Miao L; Jiang Z; Wang J; Yang N; Qi Q; Zhou W; Feng Z; Li W; Zhang Q; Huang B; Chen A; Zhang D; Zhao P; Li X
Oncol Rep; 2019 Aug; 42(2):605-614. PubMed ID: 31233190
[TBL] [Abstract][Full Text] [Related]
79. Anti-Growth, Anti-Angiogenic, and Pro-Apoptotic Effects by CX-4945, an Inhibitor of Casein Kinase 2, on HuCCT-1 Human Cholangiocarcinoma Cells via Control of Caspase-9/3, DR-4, STAT-3/STAT-5, Mcl-1, eIF-2α, and HIF-1α.
Wang S; Yadav AK; Han JY; Ahn KS; Jang BC
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35683032
[TBL] [Abstract][Full Text] [Related]
80. The protein kinase Cbeta-selective inhibitor, Enzastaurin (LY317615.HCl), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenografts.
Graff JR; McNulty AM; Hanna KR; Konicek BW; Lynch RL; Bailey SN; Banks C; Capen A; Goode R; Lewis JE; Sams L; Huss KL; Campbell RM; Iversen PW; Neubauer BL; Brown TJ; Musib L; Geeganage S; Thornton D
Cancer Res; 2005 Aug; 65(16):7462-9. PubMed ID: 16103100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
